Eva Altmann

Eva Altmann

Auto-generated profile, based on publicly available information

Eva Altmann


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Peter ErtlPeter Ertl
Peter Ertl
EAEva Altmann
Eva Altmann
JMJeffrey M. McKenna
Jeffrey M. McKenna

24 October 2016 in Nature Communications
Verified
Journal Article
Open access
ASAnita Schlierf
Anita Schlierf
EAEva Altmann
Eva Altmann
JQJean Quancard
Jean Quancard
AJAnne B. Jefferson
Anne B. Jefferson
RARené Assenberg
René Assenberg
BMBruno Martoglio
Bruno Martoglio
The COP9 signalosome (CSN) is a central component of the activation and remodelling cycle of cullin-RING E3 ubiquitin ligases (CRLs), the largest enzyme family of the ubiquitin–proteasome system in humans. CRLs are implicated in the regulation of numerous cellular processes, including cell cycle progression and apoptosis, and aberrant CRL activity is frequently associated with cancer. Remodelling of CRLs is initiated by CSN-catalysed cleavage of the ubiquitin-like activator NEDD8 from CRLs. Here we describe CSN5i-3, a potent, selective and orally available inhibitor of CSN5, the proteolytic subunit of CSN. The compound traps CRLs in the neddylated state, which leads to inactivation of a subset of CRLs by inducing degradation of their substrate recognition module. CSN5i-3 differentially affects the viability of tumour cell lines and suppresses growth of a human xenograft in mice. Our results provide insights into how CSN regulates CRLs and suggest that CSN5 inhibition has potential for anti-tumour therapy.

24 June 2014 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ASAengus Mac Sweeney
Aengus Mac Sweeney
PGPhilipp Grosche
Philipp Grosche
DEDavid Ellis
David Ellis
KCKeith Combrink
Keith Combrink
PEPaul Erbel
Paul Erbel
EAEva Altmann
Eva Altmann

30 November 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CSCarole Pissot Soldermann
Carole Pissot Soldermann
OSOliver Simic
Oliver Simic
MRMartin Renatus
Martin Renatus
PEPaulus Erbel
Paulus Erbel
SMSamu Melkko
Samu Melkko
CRCatherine H. Régnier
Catherine H. Régnier

16 December 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
EAEva Altmann
Eva Altmann
PEPaul Erbel
Paul Erbel
MRMartin Renatus
Martin Renatus
MSMichael Schaefer
Michael Schaefer
ASAnita Schlierf
Anita Schlierf
JQJean Quancard
Jean Quancard

1 February 2015 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
PGPhilipp Grosche
Philipp Grosche
FSFinton Sirockin
Finton Sirockin
ASAengus Mac Sweeney
Aengus Mac Sweeney
PRPaul Ramage
Paul Ramage
PEPaul Erbel
Paul Erbel
EAEva Altmann
Eva Altmann